[Hematological features and advancement in the diagnosis of VEXAS syndrome].
文献摘要
VEXAS syndrome is a hematologic inflammatory disorder affecting multiple systems in adults, which is caused by somatic mutations of the UBA1 gene. Its clinical manifestations are primarily refractory inflammatory symptoms and progressive hematologic abnormalities, resulting in a significant disease burden. Due to the heterogeneity of disease phenotypes and limited research, no consistently effective treatment has been established. This article focuses on the hematologic features of VEXAS syndrome, explores its pathogenic mechanisms and diagnostic evaluation systems, summarizes current treatment strategies, and proposes future research directions, with an aim to provide a basis for precise clinical identification and intervention of this disease.